Samar L. Krhili

26 Rue D'Ulm
Paris, 75005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation.

Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation.

Journal: Clinical and translational radiation oncology

Published: October 23, 2023

Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.

Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: December 16, 2022

Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.

Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.

Journal: Head & neck

Published: March 18, 2022

The role of proton therapy in esophageal cancer

The role of proton therapy in esophageal cancer

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: August 17, 2021

Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).

Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: March 30, 2020

Prognosis factors after lung stereotactic body radiotherapy for non-small cell lung carcinoma

Prognosis factors after lung stereotactic body radiotherapy for non-small cell lung carcinoma

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: August 19, 2019

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.

Journal: Cancer biology & medicine

Published: May 15, 2019

Immune gene expression in head and neck squamous cell carcinoma patients.

Immune gene expression in head and neck squamous cell carcinoma patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 06, 2019

Whole breast radiotherapy in the isocentric lateral decubitus position: Role of the immobilization device and table on clinical results.

Whole breast radiotherapy in the isocentric lateral decubitus position: Role of the immobilization device and table on clinical results.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: July 13, 2018

Patterns of locoregional failure in women with early-stage breast cancer treated by whole breast irradiation in the lateral isocentric decubitus position: Large-scale single-centre experience.

Patterns of locoregional failure in women with early-stage breast cancer treated by whole breast irradiation in the lateral isocentric decubitus position: Large-scale single-centre experience.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: May 26, 2018

Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.

Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.

Journal: American journal of clinical oncology

Published: March 31, 2016

Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.

Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.

Journal: Cancer treatment reviews

Published: March 21, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026